Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Gynaecological Cancers Congress 2024

Is there a shift in the first-line treatment of ovarian cancer?

What are our standard systemic treatment options?

Date

20 Jun 2024

Session

Is there a shift in the first-line treatment of ovarian cancer?

Topics

Tumour Site

Ovarian Cancer

Presenters

Antonio González-Martín

Authors

A. González-Martín

Author affiliations

  • Cancer Center Clínica Universidad de Navarra, Program in Solid Tumours, CIMA, and Grupo Español de Investigación en Cáncer de Ovario (GEICO), Madrid/ES

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

HRD and non-HRD

Presenter: Ilaria Colombo

Session: Is there a shift in the first-line treatment of ovarian cancer?

Resources:

Slides

Webcast

Q&A and discussion

Session: Is there a shift in the first-line treatment of ovarian cancer?

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.